EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING
2025 FIRST EGM CIRCULAR
SUPPLEMENTAL ANNOUNCEMENT
(1) PROPOSED ADOPTION OF THE 2025 A SHARE INCENTIVE SCHEME (2) PROPOSED ADOPTION OF THE 2025 H SHARE OPTION SCHEME AND (3) GRANT OF H SHARE OPTIONS UNDER THE 2025 H SHARE OPTION SCHEME
2025 INTERIM REPORT
Monthly Return of Equity Issuer on Movements in Securities
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
NOTICE OF BOARD MEETING
Monthly Return of Equity Issuer on Movements in Securities
VOLUNTARY ANNOUNCEMENT - RECOMBINANT POLIOMYELITIS VACCINE OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
1
2
3
4
5
6
50
津公网安备12011602300399
